BH3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - PTC Therapeutics Inc

Watchlist Manager

Watchlist

Price: 65.5 EUR -0.76% Market Closed

Market Cap: €4.9B

P	PTC Therapeutics Inc XBER:BH3	US
C	Cemex SAB de CV SWB:CEXA	MX
	Credit Agricole SA MIL:ACA	FR
V	Vulcan Materials Co SWB:VMC	US
K	Kering SA SWB:PPX	FR
B	Bristol-Myers Squibb Co XMUN:BRM	US
	Inventiva SA F:6IVA	FR
T	TTM Technologies Inc DUS:TT1	US

Profitability Summary

PTC Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

92%

Strong 3Y Average Gross Margin

94%

Declining Gross Margin

94% > 92%

Negative Operating Margin

-8%

Negative 3Y Average Operating Margin

-3%

Operating Margin is Increasing

-62% > -8%

Negative Net Margin

-23%

Negative 3Y Average Net Margin

-25%

Net Margin is Increasing

-74% > -23%

Negative Free Cash Flow Margin

-27%

Negative 3Y Average Free Cash Flow Margin

-1%

Free Cash Flow Margin is Increasing

-42% > -27%

Exceptional ROE

102%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

25%

ROIC is Increasing

-39% > -8%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.